# Oryl Photonics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oryl-photonics

- Industry: Medical Devices & Equipment
- Headquarters: Epalinges, Switzerland
- Website: www.orylphotonics.com
- Total disclosed funding: $0.9M
- Latest round: Series A (Sep 17, 2025)
- Investors on record: 2

## About

Based in Epalinges, Switzerland, and founded in 2020, Oryl Photonics SA operates as a medical equipment manufacturing company that provides laboratory instruments based on proprietary light scattering technology. Orly Tarun and Nathan Dupertuis are the co-founders of the company. In September 2025, Oryl Photonics SA raised an undisclosed amount of series A funding from unspecified investors.

The company specializes in the design and manufacturing of customized wide-field nonlinear optical microscopes and nonlinear light scattering devices. The firm’s technology enables users to offer solutions for a wide range of applications in the life sciences, semiconductor industry, and medicine. Oryl’s primary product, the Easy Screener, utilizes second harmonic scattering to provide rapid and accurate solubility testing. This approach allows researchers to assess the solubility and aggregation of compounds with speed and precision. In addition, Oryl offers customized wide-field nonlinear optical microscopes and nonlinear light scattering devices via its suite of products.

The company will use the September 2025 funding to commercialize its lab instrument, expand solubility testing services, and prepare for scaling.

## Funding rounds

- Series A, Sep 17, 2025 — S2S Ventures, Cadfem Group
- Seed, Feb 6, 2024, $0.9M — S2S Ventures, Cadfem Group

## Investors

- S2S Ventures (https://capitalatlas.ai/funds/s2s-ventures) — Seed, Series A
- Cadfem Group — Seed, Series A